Our administration has recently directed use of the BioFlo Midline product and education of staff. I just became aware. I had, over the past two years implemented sucessful use of the Powerglide PIV. I am of the understanding that the purported decreased Thrombus rate was the rationale, however after doing some research, there have not been any, to our knowledge. I am really at a loss. I am looking for any rationale that I can use to support our IV nurses and the other key staff we have educated to insert the Powerglide PIV's, as they appear to accomplish the same function, with less insertion time and no need for a "cut". Does anyone have experience with either or both who can assist me either way to make a case? Thank you in advance.